1. Home
  2. SWVL vs IRIX Comparison

SWVL vs IRIX Comparison

Compare SWVL & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Swvl Holdings Corp

SWVL

Swvl Holdings Corp

HOLD

Current Price

$1.80

Market Cap

15.6M

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.07

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWVL
IRIX
Founded
2017
1989
Country
United Arab Emirates
United States
Employees
284
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
18.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SWVL
IRIX
Price
$1.80
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.4K
161.2K
Earning Date
04-20-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.87
52 Week High
$4.99
$1.65

Technical Indicators

Market Signals
Indicator
SWVL
IRIX
Relative Strength Index (RSI) 63.68 42.58
Support Level $1.33 $1.01
Resistance Level $3.83 $1.18
Average True Range (ATR) 0.14 0.05
MACD 0.04 0.02
Stochastic Oscillator 72.82 44.44

Price Performance

Historical Comparison
SWVL
IRIX

About SWVL Swvl Holdings Corp

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: